Original articleEffect of escitalopram on hot flash interference: a randomized, controlled trial
Key Words
Cited by (0)
J.S.C. has nothing to disclose. K.A.G. has nothing to disclose. J.C.L. has nothing to disclose. E.W.F. has nothing to disclose. H.J. receives research support (to the Center for Women's Mental Health at Massachusetts General Hospital where she participates in protocols as a co-investigator) from Bayer HealthCare Pharmaceuticals, Forest Laboratories, and GlaxoSmithKline and has consulted for Sanofi-Aventis/Sunovion. S.D.R. has nothing to disclose. K.E.E. has nothing to disclose. A.Z.L. has nothing to disclose.
Supported by the National Institute of Aging, in collaboration with the Eunice Kennedy Shriver National Institute of Child Health and Development, the National Center for Complementary and Alternative Medicine, the Office of Research and Women's Health, and grants U01AG032656, U01AG032659, U01AG032669, U01AG032682, U01AG032699, and U01AG032700. At Indiana, the project was supported by the Indiana Clinical and Translational Sciences Institute (UL1 RR025761) from the National Center for Research Resources, Clinical and Translational Sciences Award.